These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11688537)

  • 1. Linezolid: pharmacokinetic characteristics and clinical studies.
    Bouza E; Muñoz P
    Clin Microbiol Infect; 2001; 7 Suppl 4():75-82. PubMed ID: 11688537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of linezolid in children: an overview of recent advances.
    Velissariou IM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):947-52. PubMed ID: 17181410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid for the treatment of resistant gram-positive cocci.
    Bain KT; Wittbrodt ET
    Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid: a review of its use in the management of serious gram-positive infections.
    Perry CM; Jarvis B
    Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
    Corti G; Cinelli R; Paradisi F
    Int J Antimicrob Agents; 2000 Dec; 16(4):527-30. PubMed ID: 11118873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid in children: recent patents and advances.
    Velissariou IM
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):73-7. PubMed ID: 18221164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid: an oxazolidinone antimicrobial agent.
    Fung HB; Kirschenbaum HL; Ojofeitimi BO
    Clin Ther; 2001 Mar; 23(3):356-91. PubMed ID: 11318073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.
    Burkhardt O; Pletz MW; Mertgen CP; Welte T
    Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):123-30. PubMed ID: 18221168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactic acidosis after treatment with linezolid.
    Wiener M; Guo Y; Patel G; Fries BC
    Infection; 2007 Jun; 35(4):278-81. PubMed ID: 17646908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tedizolid: a new oxazolidinone antimicrobial.
    Kisgen JJ; Mansour H; Unger NR; Childs LM
    Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid--a review of the first oxazolidinone.
    Norrby R
    Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid: in infants and children with severe Gram-positive infections.
    Lyseng-Williamson KA; Goa KL
    Paediatr Drugs; 2003; 5(6):419-29; discussion 430-1. PubMed ID: 12765493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of linezolid in children.
    Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of linezolid in antimicrobial therapy].
    Carmona PM; Romá E; Monte E; García J; Gobernado M
    Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):30-41. PubMed ID: 12550042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Linezolid].
    Yanagihara K; Yanagihara K; Kohno S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():352-9. PubMed ID: 17455645
    [No Abstract]   [Full Text] [Related]  

  • 17. Linezolid Pharmacia Corp.
    Barrett JF
    Curr Opin Investig Drugs; 2000 Oct; 1(2):181-7. PubMed ID: 11249571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid: a review of safety and tolerability.
    Vinh DC; Rubinstein E
    J Infect; 2009 Sep; 59 Suppl 1():S59-74. PubMed ID: 19766891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
    Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
    Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.